Detail akcie LeMaitre online

Business Summary: LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, LeMaitre Vascular Inc revenues increased 20% to $193.5M. Net income increased 46% to $30.1M. Revenues reflect United States segment increase of 18% to $117.8M, Canada segment increase of 29% to $10.8M. Net income benefited from Restructuring decrease of 84% to $485K (expense), Interest Income increase from $986K to $3.1M (income). Dividend per share increased from $0.49 to $0.55.